# Comparative Trial Evaluating Safety and Immunogenicity of an Adjuvanted and a Conventional Influenza Vaccine in Elderly Subjects (> 60 Years)

> **NCT00310648** · PHASE3 · COMPLETED · sponsor: **Novartis** · enrollment: 600 (—)

## Conditions studied

- Influenza

## Interventions

- **BIOLOGICAL:** Influenza vaccine

## Key facts

- **NCT ID:** NCT00310648
- **Lead sponsor:** Novartis
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2006-01
- **Primary completion:** —
- **Final completion:** —
- **Target enrollment:** 600 (—)
- **Last updated:** 2006-09-14

## Collaborators

- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00310648

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00310648, "Comparative Trial Evaluating Safety and Immunogenicity of an Adjuvanted and a Conventional Influenza Vaccine in Elderly Subjects (> 60 Years)". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT00310648. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*